CAN RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS DECREASE CARDIOVASCULAR RISK?

被引：0
|
作者：
Gudu, Tania [1 ]
Mazilu, Diana [1 ,2 ]
Peltea, Alexandra [1 ]
Opris, Daniela [1 ,2 ]
Ionescu, Ruxandra [1 ,2 ]
机构：
[1] Sfanta Maria Hosp, Dept Rheumatol & Internal Med, Bucharest, Romania
[2] Carol Davila Univ Med, Bucharest, Romania
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2013-205124.84
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1.85
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [21] Hypogammaglobulinemia in rheumatoid arthritis patients on rituximab: prevalence and risk factors
    Opdam, Merel A. A.
    Campisi, Laura M.
    de Leijer, J. H.
    ten Cate, David
    den Broeder, Alfons A.
    RHEUMATOLOGY, 2024, 63 (01) : e1 - e2
  • [22] THE RISK OF SERIOUS INFECTIONS IN PATIENTS RECEIVING RITUXIMAB FOR RHEUMATOID ARTHRITIS
    Silva-Fernandez, L.
    Lunt, M.
    Low, A. S.
    Watson, K. D.
    Symmons, D. P.
    Hyrich, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 70 - 71
  • [23] Cardiovascular risk factors in Rheumatoid Arthritis (RA) patients: Can these be modified by a Mediterranean diet?
    McEntegart, A.
    Hampson, R.
    Tierney, A.
    Morrison, E.
    RHEUMATOLOGY, 2006, 45 : I93 - I93
  • [24] Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
    Hloch, Karel
    Dosedel, Martin
    Tebbens, Jurjen Duintjer
    Zaloudkova, Lenka
    Medkova, Helena
    Vlcek, Jiri
    Soukup, Tomas
    Pavek, Petr
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [25] The relation of disease activity and treatment with the risk of cardiovascular disease in patients with rheumatoid arthritis
    Welsing, PM
    Kievit, W
    Fransen, J
    van Riel, PL
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S323 - S323
  • [26] Inadequate Cardiovascular Disease Risk Screening and Preventative Treatment in Patients with Rheumatoid Arthritis
    Munawar, Tooba
    Khokhar, Farzam
    Perl, Andras
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2738 - 2740
  • [27] Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project
    van den Oever, Inge A. M.
    Heslinga, Maaike
    Griep, Ed N.
    Griep-Wentink, Hanneke R. M.
    Schotsman, Rob
    Cambach, Walter
    Dijkmans, Ben A. C.
    Smulders, Yvo M.
    Lems, Willem F.
    Boers, Maarten
    Voskuyl, Alexandre E.
    Peters, Mike J. L.
    van Schaardenburg, Dirkjan
    Nurmohamed, Micheal T.
    RHEUMATOLOGY, 2017, 56 (09) : 1472 - 1478
  • [28] RITUXIMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS RELATED LUNG DISEASE
    Iqbal, K.
    Kelly, C.
    Saravanan, V.
    Rynne, M.
    Hamilton, J.
    Heycock, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 385 - 385
  • [29] Treatment of rheumatoid arthritis may reduce cardiovascular risk
    Pinn, Stephen
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (12) : 674 - 674
  • [30] Rheumatoid arthritis and cardiovascular risk: perspectives of treatment with statins
    Anichkov, D. A.
    Shostak, N. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2005, 1 (03) : 47 - 53
12345